Other research has shown that the oncogene RAF1, as targeted by microRNA miR-7-5p, is associated with microvascular proliferation of GBM (Liu et al. 2014 in Supplementary notes T1), and the finding that miR-424 actives RAF1 in ERBB signaling which may be associated with apoptosis in GBM cells, indicating a possible target on RAF1 for antitumor drug research (Gheidari et al. 2021 in Supplementary notes T1). This evidence concerns the gene RAF1 and glioblastoma.